Office of Policy, Legislation, and International Affairs
FDA’s Office of Policy, Legislation and International Affairs (OPLIA) is comprised of a constellation of offices and staff, with employees stationed around the globe. Our offices include FDA’s Office of Policy, Office of Legislation, Office of Congressional Appropriations, Office of Global Policy and Strategy, Office of Economics and Analysis and the Intergovernmental Affairs Staff.
Within FDA, OPLIA has a significant and wide-reaching role. Our staff serves as FDA’s focal point for engagement with the U.S. Congress, the Administration, global counterparts and partners, and state, local, territorial, and tribal policymakers. We offer strategic policy direction to develop and advance policies that protect and promote the public health.
OPLIA is led by the Deputy Commissioner for Policy, Legislation, and International Affairs. Our work requires collaboration and ingenuity which is only enhanced by the range of professional backgrounds OPLIA staff bring to the table – including law, science, policy, economics, and management. OPLIA’s work is also positively influenced by our staff’s personal commitment to FDA’s mission to serve the public health.
Mission
Through strategic leadership and engagement with diverse partners, including domestic, tribal, and international decision-makers, OPLIA utilizes our cross-cutting perspective of FDA, expertise in policy, economic analysis, legislation, international and intergovernmental affairs, and understanding of FDA’s stakeholders’ needs, to develop and advance policies that protect and promote the public health.
Vision
Maximize FDA’s effectiveness by serving as trusted partners and the Agency’s nexus to shape and drive policy and priorities, resulting in a healthier country and world.